Abstract: FIeroxecin, a new fluroquinolone antibacterlal agent, has a broad spectrum of in vitro activity which encompasses most Gram-negative and a number of Cram-positive organisms including methiclllin-sensitive staphylococcl. Its antibacterlal activity, pharmac